# Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus

> **NCT00134940** · — · COMPLETED · sponsor: **Novartis** · enrollment: 100 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00134940
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134940, "Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00134940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*